XOMA Corp
NASDAQ:XOMA

Watchlist Manager
XOMA Corp Logo
XOMA Corp
NASDAQ:XOMA
Watchlist
Price: 21.16 USD -3.02% Market Closed
Market Cap: 249.3m USD
Have any thoughts about
XOMA Corp?
Write Note

P/OCF
Price to OCF

-16.8
Current
-12.7
Median
19.9
Industry
Lower than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-16.8
=
Market Cap
248.7m USD
/
Operating Cash Flow
-14.8m USD
All Countries
Close
Market Cap P/OCF
US
XOMA Corp
NASDAQ:XOMA
248.7m USD -16.8
FR
Pharnext SCA
OTC:PNEXF
6T USD -229 866.7
US
Abbvie Inc
NYSE:ABBV
382.5B USD 20.3
US
Amgen Inc
NASDAQ:AMGN
175.8B USD 15.3
US
Gilead Sciences Inc
NASDAQ:GILD
146B USD 13.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
128.5B USD -260.8
US
Epizyme Inc
F:EPE
94.1B EUR -489.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.6B USD 18.5
AU
CSL Ltd
ASX:CSL
121.1B AUD 25.8
US
Seagen Inc
F:SGT
39.3B EUR -79
NL
argenx SE
XBRU:ARGX
31.8B EUR -132.7
 
US
XOMA Corp
NASDAQ:XOMA
Average P/OCF: 18.7
Negative Multiple: -16.8
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -229 866.7
US
Abbvie Inc
NYSE:ABBV
20.3
US
Amgen Inc
NASDAQ:AMGN
15.3
US
Gilead Sciences Inc
NASDAQ:GILD
13.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -260.8
US
E
Epizyme Inc
F:EPE
Negative Multiple: -489.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.5
AU
CSL Ltd
ASX:CSL
25.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -79
NL
argenx SE
XBRU:ARGX
Negative Multiple: -132.7

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A